Kevin MD - INVO Bioscience Medical Director

INVODelisted Stock  USD 0.84  0.03  3.45%   

Insider

Kevin MD is Medical Director of INVO Bioscience
Age 65
Phone978 878 9505
Webhttps://www.invobioscience.com

INVO Bioscience Management Efficiency

The company has return on total asset (ROA) of (0.2657) % which means that it has lost $0.2657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (143.5864) %, meaning that it created substantial loss on money invested by shareholders. INVO Bioscience's management efficiency ratios could be used to measure how well INVO Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.
INVO Bioscience currently holds 8.68 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. INVO Bioscience has a current ratio of 1.95, which is within standard range for the sector. Note, when we think about INVO Bioscience's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Rhon GalichaCLPS Inc
N/A
Ming LinCLPS Inc
60
Robert WeingartenLixte Biotechnology Holdings
72
Joseph TuckerEnveric Biosciences
55
Miranda MBAEntera Bio
47
iur LLMNLS Pharmaceutics AG
58
Li LiCLPS Inc
48
Ibrahim MDEnveric Biosciences
55
Sharon KeysNLS Pharmaceutics AG
N/A
Xiao YangCLPS Inc
60
Srustijeet MishraCLPS Inc
N/A
James MDLixte Biotechnology Holdings
77
II MDEntera Bio
71
Rui YangCLPS Inc
41
Peter FacchiniEnveric Biosciences
60
Eric JDLixte Biotechnology Holdings
45
Chad MBANLS Pharmaceutics AG
N/A
Hillel MBAEntera Bio
46
Avani KanubaddiEnveric Biosciences
51
MBA IVEnveric Biosciences
68
Wilson WongCLPS Inc
N/A
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. The company was founded in 2007 and is based in Sarasota, Florida. Invo Bioscience operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. INVO Bioscience (INVO) is traded on NASDAQ Exchange in USA and employs 25 people.

Management Performance

INVO Bioscience Leadership Team

Elected by the shareholders, the INVO Bioscience's board of directors comprises two types of representatives: INVO Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INVO. The board's role is to monitor INVO Bioscience's management team and ensure that shareholders' interests are well served. INVO Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INVO Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kevin MD, Medical Director
FACS FACOG, VP Integration
Bojan Mitrovic, Director US
Lori MarzilliKahler, VP Operations
Michael Campbell, COO Development
Terah Krigsvold, Controller
Chris Myer, Sr Americas
Steven Shum, CEO Director
Andrea Goren, Chief Officer
Robert Bowdring, Treasurer Secretary

INVO Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INVO Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with INVO Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving against INVO Stock

  0.58MCD McDonalds Fiscal Year End 3rd of February 2025 PairCorr
  0.58IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.49GE GE Aerospace Fiscal Year End 28th of January 2025 PairCorr
  0.41MMM 3M Company Fiscal Year End 28th of January 2025 PairCorr
The ability to find closely correlated positions to INVO Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INVO Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INVO Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INVO Bioscience to buy it.
The correlation of INVO Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INVO Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in INVO Stock

If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.